Generate Biomedicines Inc (GENB) Price Prediction & ForecastGENBGenerate Biomedicines Inc

Alphio's GENB stock price prediction model matches the current Generate Biomedicines Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $12.20 (+0.88%). The 1-week path is $11.85 (-2.00%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Generate Biomedicines, Inc. is not a good buy right now due to significant financial losses and declining revenues. The current price is $12.09, with a 5-day change of -15.69% and a year-to-date change of -24.44%. The company reported a net loss of $67.3 million in Q2 2026, which is a widening loss compared to the previous year, indicating ongoing financial struggles. Additionally, the RSI is at 29, suggesting the stock is oversold but may not rebound soon. The main risk is the company's cash burn rate, which could lead to dilution, as they have $516.6 million in cash reserves that need to be managed effectively over the next two years.

Generate Biomedicines Inc (GENB) last closed at $12.09, losing -7.43%. These facts feed the 1-day and 1-week GENB price prediction above.